Today: 1 February 2026
Subscribe
Browse Category

Investment News News 8 December 2025

Structure Therapeutics (GPCR) Stock Soars on Obesity Pill Data: Latest News, Analyst Forecasts and 2026 Outlook (December 8, 2025)

Structure Therapeutics (GPCR) Stock Soars on Obesity Pill Data: Latest News, Analyst Forecasts and 2026 Outlook (December 8, 2025)

Structure Therapeutics Inc. (NASDAQ: GPCR) just turned a long‑anticipated clinical readout into a full‑blown stock market event. On Monday, December 8, 2025, the company released positive topline data from its ACCESS program for aleniglipron (GSBR‑1290), a once‑daily oral GLP‑1 receptor agonist for obesity. The market response was immediate: GPCR closed at $69.46, up about 101% on the day, after trading…
8 December 2025
····
Oklo Inc. (OKLO) Stock: Latest News, Price Targets and 2026 Nuclear Outlook as of December 8, 2025

Oklo Inc. (OKLO) Stock: Latest News, Price Targets and 2026 Nuclear Outlook as of December 8, 2025

Oklo Inc. (NYSE: OKLO) has turned into one of 2025’s most explosive energy trades. The advanced nuclear start‑up is still pre‑revenue, but its share price has rocketed more than 400% this year, lifted by hype around small reactors that could power AI data centers, new U.S. government pilot programs, and a wave of analyst coverage. Investorsobserver As of 8 December…
8 December 2025
····
CoreWeave (CRWV) Stock Falls on $2 Billion Convertible Notes – What December 8 Means for the AI Cloud High‑Flyer

CoreWeave (CRWV) Stock Falls on $2 Billion Convertible Notes – What December 8 Means for the AI Cloud High‑Flyer

Published: December 8, 2025 Key takeaways Important: This article is for information purposes only and does not constitute financial advice. Always do your own research or consult a licensed adviser before investing. CoreWeave stock today: price action on December 8, 2025 CoreWeave shares are under pressure to start the week as the market digests yet another large funding round from…
8 December 2025
···
Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Published: December 8, 2025 Dyne Therapeutics (NASDAQ: DYN) is back on biotech investors’ radar after releasing highly anticipated topline data from its Phase 1/2 DELIVER trial in Duchenne muscular dystrophy (DMD), sending the stock sharply higher on Monday. By mid‑afternoon on December 8, Dyne shares were trading around $23.20, up roughly 14% on the day, after opening at $21.59 and…
8 December 2025
···
Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

U.S. stocks traded mostly flat on Monday as Wall Street headed into a crucial Federal Reserve meeting, but under the surface the tape was anything but quiet. While the S&P 500 and Dow Jones Industrial Average hovered around unchanged and the Nasdaq 100 eked out a small gain, small‑cap and high‑beta names ripped higher, led by a wave of biotech…
8 December 2025
····
Global Stock Market Today, December 8, 2025: Fed Rate-Cut Bets Keep World Equities Near Record Highs

Global Stock Market Today, December 8, 2025: Fed Rate-Cut Bets Keep World Equities Near Record Highs

Global stock markets started the week in a holding pattern on Monday, December 8, 2025, as investors wait for what is widely expected to be a US Federal Reserve rate cut — and, more importantly, clues about how far and how fast any easing cycle might go. World equities were broadly flat, with Asia mixed but mostly firmer, European stocks…
8 December 2025
····
US Stock Futures Today, December 8, 2025: Dow, S&P 500 and Nasdaq Edge Higher Ahead of Fed Rate Cut Decision

US Stock Futures Today, December 8, 2025: Dow, S&P 500 and Nasdaq Edge Higher Ahead of Fed Rate Cut Decision

U.S. stock futures traded slightly higher early Monday, December 8, 2025, as Wall Street enters a pivotal “Fed week” with investors overwhelmingly betting on an interest rate cut and major indexes hovering near record highs. Investing US stock futures today at a glance By around 6:00–7:30 a.m. ET on Monday: Coverage from Reuters, Investing.com, Yahoo Finance and others characterizes the…
8 December 2025
····
iRobot Stock Rockets on Robotics Hype While Bankruptcy Fears Deepen – IRBT Update for December 8, 2025

iRobot Stock Rockets on Robotics Hype While Bankruptcy Fears Deepen – IRBT Update for December 8, 2025

Ticker: iRobot Corporation (NASDAQ: IRBT)Date: December 8, 2025 iRobot’s stock has suddenly gone from “left for dead” penny territory to a meme‑adjacent, policy‑driven rocket ship. In early December, shares of the Roomba maker more than doubled in a few trading sessions on speculation that the White House is preparing a major push to support the U.S. robotics industry, even as…
8 December 2025
····
Canara Bank Share Price Today (8 December 2025): Rally Cools After 52-Week Highs, Q2 FY26 Earnings, AT1 Bonds and Fresh $100 Million Loan

Canara Bank Share Price Today (8 December 2025): Rally Cools After 52-Week Highs, Q2 FY26 Earnings, AT1 Bonds and Fresh $100 Million Loan

Canara Bank’s stock has had a busy few weeks — new 52‑week highs, strong Q2 FY26 results, a big AT1 bond issue, a lending-rate cut, and even a fresh US$100 million offshore loan. On 8 December 2025, the share price is consolidating after a sharp run-up, while most analysts remain broadly positive but a bit more cautious on upside. Canara…
8 December 2025
····
Reliance Industries Share Price Today, 8 Dec 2025: RIL Outperforms Nifty on Jio IPO, AI and Green Energy Triggers

Reliance Industries Share Price Today, 8 Dec 2025: RIL Outperforms Nifty on Jio IPO, AI and Green Energy Triggers

Reliance Industries (RIL) share price today hovers near record highs as investors price in the Jio IPO, AI partnerships, data centres and a massive green energy build‑out. Here’s a deep dive into the latest news, forecasts and risks around the stock as of 8 December 2025. Reliance Industries share price today (8 December 2025) Reliance Industries Limited (RIL) traded around…
8 December 2025
···
Kaynes Technology Share Price Slides 43% From October Peak as Kotak Flags Accounting Issues; Management Defends FY25 Numbers on December 8 Call

Kaynes Technology Share Price Slides 43% From October Peak as Kotak Flags Accounting Issues; Management Defends FY25 Numbers on December 8 Call

Mumbai, December 8, 2025 — Electronics manufacturing services (EMS) player Kaynes Technology India Ltd is in the eye of a governance storm after a hard-hitting report from Kotak Institutional Equities triggered a sharp sell-off, a flurry of clarifications from management, and an emergency analyst call on Monday morning. The stock, once a market darling, has now fallen about 43.5% from…
8 December 2025
···
Jardine Matheson Holdings 2025 Outlook: New CEO, $250m Buyback and Mandarin Oriental Deal Signal a New Era

Jardine Matheson Holdings 2025 Outlook: New CEO, $250m Buyback and Mandarin Oriental Deal Signal a New Era

Jardine Matheson Holdings Limited (Jardine Matheson, SGX:J36; LSE:JAR; OTC:JMHLY) is closing out 2025 in full restructuring mode. A US$4.2 billion bid to take Mandarin Oriental private, a US$250 million share buyback and a leadership change that brings in a private‑equity veteran as CEO are together reshaping how investors view the 193‑year‑old Asian conglomerate. Reuters On 8 December 2025, Mandarin Oriental…
8 December 2025
···
1 … 149 150 151 152 153 … 195

Stock Market Today

  • Austevoll Seafood Stock Review: Valuation, Returns, and Market Outlook
    February 1, 2026, 12:00 PM EST. Austevoll Seafood (OB:AUSS) has shown mixed recent share performance with a 1.53% gain in the last week but a 6.17% decline over 30 days. The 1-year total return is negative at -10.24%, contrasting with positive returns over 3 and 5 years. The company reported growing annual revenue of NOK 38,995 million and net income of NOK 1,339 million. Current share price is NOK 92.7, below the fair value estimate of NOK 108.50, indicating potential undervaluation. Growth hinges on rising demand for high-protein seafood and expanding higher-value products. Risks include seafood price volatility and regulatory changes in Chile. Investors should weigh short-term weakness against longer-term prospects amid shifting consumer trends.
Go toTop